Dungey Alison A, Badhwar Amit, Bihari Aurelia, Kvietys Peter R, Harris Kenneth A, Forbes Thomas L, Potter Richard F
Centre for Critical Illness Research, Lawson Health Research Institute, London, Ontario, Canada.
Microcirculation. 2006 Mar;13(2):71-9. doi: 10.1080/10739680500466228.
Ischemic tolerance (IT) is known to improve resistance to ischemia/reperfusion (I/R)-induced injury; however, the mechanisms remain unknown. The authors hypothesized that induction of heme oxygenase (HO), a heat shock protein, would provide anti-inflammatory benefits during IT, thereby preventing leukocyte-derived I/R injury.
Male Wistar rats were randomly assigned to sham (n = 4), I/R (n = 9), preconditioning (PC)+I/R (n = 7), chromium mesoporphyrin, to inhibit HO (CrMP; n = 4), or PC+I/R+CrMP (n = 6) groups. PC consisted of 5 cycles of I/R, each lasting 10 min, induced by tightening a tourniquet placed above the greater trochantor of the hindlimb. Twenty-four hours later, the hindlimb underwent 2 h of no-flow ischemia followed by intravital microscopy during 90 min reperfusion to assess capillary perfusion (#/mm), tissue injury (ratio of ethidium bromide to bisbenzimide labeled cells/100 microm2), leukocyte rolling (Lr, #/1000 microm2), and adhesion (La, #/1000 microm2) in postcapillary venules of the extensor digitorum longus (EDL) muscle.
In the I/R group, Lr was significantly increased (7.1 +/- 0.4) compared to sham (3.1 +/- 0.4). PC+I/R increased Lr (10.8 +/- 0.72), which was further exacerbated by the removal of HO (14.2 +/- 1.3). La (7.8 +/- 2.0) was significantly increased compared to sham (2.4 +/- 0.9), while PC returned La back to sham levels (1.9 +/- 0.7). Removal of HO activity, via CrMP, had no significant effect on La (3.9 +/- 0.7). However, CrMP removed the protection to microvascular perfusion (I/R = 9.4 +/- 1.1, PC = 16.6 +/- 1.8, sham = 20.5 +/- 2.8, PC+CrMP+I/R = 12.3 +/- 2.3) and prevented protection from ischemia-induced tissue injury.
The data suggest that HO is an important protective mechanism during IT in skeletal muscle, but such protection was by mechanisms other than altered leukocyte-endothelial cell interaction.
已知缺血耐受(IT)可提高对缺血/再灌注(I/R)诱导损伤的抵抗力;然而,其机制仍不清楚。作者推测,诱导热休克蛋白血红素加氧酶(HO)在缺血耐受期间将提供抗炎益处,从而预防白细胞源性的I/R损伤。
将雄性Wistar大鼠随机分为假手术组(n = 4)、I/R组(n = 9)、预处理(PC)+I/R组(n = 7)、用中卟啉铬抑制HO的组(CrMP;n = 4)或PC+I/R+CrMP组(n = 6)。预处理包括5个I/R周期,每个周期持续10分钟,通过收紧置于后肢大转子上方的止血带诱导。24小时后,后肢经历2小时无血流缺血,随后在90分钟再灌注期间进行活体显微镜检查,以评估趾长伸肌(EDL)肌毛细血管后微静脉中的毛细血管灌注(#/mm)、组织损伤(溴化乙锭与双苯甲酰亚胺标记细胞的比率/100平方微米)、白细胞滚动(Lr,#/1000平方微米)和黏附(La,#/1000平方微米)。
与假手术组(3.1±0.4)相比,I/R组的Lr显著增加(7.1±0.4)。PC+I/R组使Lr增加(10.8±0.72),而去除HO后进一步加剧(14.2±1.3)。与假手术组(2.4±0.9)相比,La(7.8±2.0)显著增加,而预处理使La恢复到假手术组水平(1.9±0.7)。通过CrMP去除HO活性对La无显著影响(3.9±0.7)。然而,CrMP消除了对微血管灌注的保护作用(I/R组=9.4±1.1,PC组=16.6±1.8,假手术组=20.5±2.8,PC+CrMP+I/R组=12.3±2.3),并阻止了对缺血诱导的组织损伤的保护。
数据表明,HO是骨骼肌缺血耐受期间的一种重要保护机制,但这种保护是通过改变白细胞-内皮细胞相互作用以外的机制实现的。